Lv31
340 积分 2025-04-11 加入
Pharmacokinetics, pharmacodynamics, safety, and tolerability of hyzetimibe (HS-25) in healthy Chinese subjects
1个月前
已完结
New Insights Into the Importance of Dietary Cholesterol in Preventing Cardiovascular Disease
2个月前
已关闭
Upfront lipid-lowering combination therapy in high cardiovascular risk patients: a route to effective atherosclerotic cardiovascular disease prevention
2个月前
已关闭
Vulnerable or High-Risk Plaque
2个月前
已完结
Vulnerable plaque and major adverse cardiovascular events: anatomy of a failure
2个月前
已关闭
Efficacy and safety of ongericimab in Chinese patients with heterozygous familial hypercholesterolemia: a randomized, double-blind, placebo-controlled phase 3 trial
2个月前
已完结
Vulnerable or High-Risk Plaque
3个月前
已完结
Should Patients With Myocardial Infarction Be Started on Combination Therapy With Ezetimibe Before Hospital Discharge?
3个月前
已完结
皖公网安备34019202002308
